The epidemiology of Wegener's granulomatosis and microscopic polyangiitis in a Southern Hemisphere region

Rheumatology

Volumn 45, Issue 5, 2006, Pages 624-628

  Gibson, A ^a   Stamp, L K ^a,b   Chapman, P T ^a,b   O'Donnell, John L ^a,b,c  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b UNIVERSITY OF OTAGO   (New Zealand)

^c CANTERBURY HEALTH LABORATORIES   (New Zealand)

Author keywords

Epidemiology; Microscopic polyangiitis; Southern Hemisphere; Wegener's granulomatosis

Indexed keywords

NEUTROPHIL CYTOPLASMIC ANTIBODY;

ACUTE DISEASE; ADULT; ARTICLE; CALCULATION; CHILD; CLINICAL FEATURE; CONFIDENCE INTERVAL; DATA BASE; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GLOMERULONEPHRITIS; GLOMERULOPATHY; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROSCOPIC POLYANGIITIS; MORTALITY; NEW ZEALAND; PREVALENCE; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; WEGENER GRANULOMATOSIS;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; FEMALE; HUMANS; MALE; MIDDLE AGED; NEW ZEALAND; PREVALENCE; VASCULITIS; WEGENER GRANULOMATOSIS;

EID: 33646235640     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kei259     Document Type: Article

References (13)

1. Scott D, Watts R. Systemic vasculitis: Epidemiology, classification and environmental factors. Ann Rheum Dis 2000;59:161-3.
2. Mahr A, Guillevin L, Poissonnet M, Ayme S. Prevalence of polyarteritis nodosa, microscopic polyangiitis, Wegener's granulomatosis, and Churg-Strauss syndrome in a French urban multiethnic population in 2000: a capture-recapture estimate. Arthritis Care Res 2004;51:92-9.
3. Koldingsnes W, Nossent H. Epidemiology of Wegener's granulomatosis in northern Norway. Arthritis Rheum 2000;43:2481-7.
4. Leavitt R, Fauci A, Bloch et al. The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum 1990;33:1101-7.
5. Jennnette J, Falk R, Andrassy K et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994;37:187-92.
6. Statistics New Zealand. 2001 Census; Final counts 2001; Census of populations and dwellings 2001; Canterbury Region. www.stats.govt.nz
7. Watts R, Lane S, Bentham G, Scott D. Epidemiology of systemic vasculitis. A ten year study in the United Kingdom. Arthritis Rheum 2000;43:414-19.
8. Andrews M, Edmunds M, Campbell A, Walls J, Feehally J. Systemic vasculitis in the 1980s - is there an increasing incidence of Wegener's granulomatosis and microscopic polyarteritis? J R Coll Physicians Lond 1990;24:284-8.
9. Reinhold-Keller E, Herlyn K, Wagner-Bastmeyer R et al. No difference in the incidences of vasculitides between north and south Germany: First results of the German vasculitis Register. Rheumatology 2002;41:540-9.
10. Reinhold-Keller E, Herlyn K, Wagner-Bastmeyer R, Gross W. Stable incidence of primary systemic vasculitides over five years: Results from the German vasculitis register. Arthritis Care Res 2005;53:93-9.
11. Cotch M, Hoffman G, Yerg D, Kaufman G, Targonski P, Kaslow R. The epidemiology of Wegener's granulomatosis: Estimates of the five year period prevalence, annual mortality and geographic disease distribution from population-based data sources. Arthritis Rheum 1996;39:87-92.
12. Gonzalez-Gay MA G-PC, Guerrero J, Rodriquez-Ledo P, Llorca J. The epidemiology of the primary systemic vasculitides in north-western Spain: Implications of the Chapel Hill Consensus Conference definitions. Arthritis Rheum (Arthritis Care Res) 2003;49:388-93.
13. Hoffman G, Specks U. Antineutrophil cytoplasmic antibodies. Arthritis Rheum 1998;41:1521-37.